Survival of patients receiving systematic therapy for metachronous or synchronous metastatic renal cell carcinoma: a retrospective analysis

BACKGROUND: The differences in progression-free survival (PFS) and cancer-specific survival (CSS) of metastatic renal cell carcinoma (mRCC) patients according to treatment, type of metastasis, and Heng criteria risk are unclear. In this study, we compared survival according to various such parameter...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Cancer
Autors principals: Kim, Sung Han, Lee, Dong-eun, Park, Boram, Joo, Jungnam, Joung, Jae Young, Seo, Ho Kyung, Lee, Kang Hyun, Chung, Jinsoo
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2019
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6631605/
https://ncbi.nlm.nih.gov/pubmed/31307432
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-5900-1
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars